Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_assertion type Assertion NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_head.
- NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_assertion description "[Here, we demonstrate that for one patient, with the first reported fibroblast growth factor receptor 2 (FGFR2) fusion transcript in ovarian cancer, circulating tumor DNA (ctDNA) is a more sensitive and specific biomarker than CA125, and it can also inform on a candidate therapeutic.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_provenance.
- NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_assertion evidence source_evidence_literature NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_provenance.
- NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_assertion SIO_000772 24563622 NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_provenance.
- NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_assertion wasDerivedFrom befree-2016 NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_provenance.
- NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_assertion wasGeneratedBy ECO_0000203 NP1157599.RA0hF4ijSmbawDpmX3fmiefXE4E-fObxje3XDIadXnWBU130_provenance.